Link to this page
Medical Subject Headings
| Preferred Name | Dabigatran | |
| Synonyms |
Mesylate, Dabigatran Etexilate Pradaxa N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine BIBR 1048 Dabigatran Etexilate Etexilate, Dabigatran Etexilate Mesylate, Dabigatran Dabigatran Etexilate Mesylate |
|
| Definitions |
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000069604 |
|
| altLabel |
Mesylate, Dabigatran Etexilate Pradaxa N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine BIBR 1048 Dabigatran Etexilate Etexilate, Dabigatran Etexilate Mesylate, Dabigatran Dabigatran Etexilate Mesylate
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C2343849 C2348066 C2940579 C1571583 C1122231
|
|
| DC |
1
|
|
| definition |
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
|
|
| DX |
20160101
|
|
| HN |
2016 (2002)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
I0VM4M70GC SC7NUW5IIT 2E18WX195X 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015
|
|
| Mapped from | ||
| MDA |
20150710
|
|
| MMR |
20160528
|
|
| MN |
D03.383.725.192 D03.633.100.103.280
|
|
| notation |
D000069604
|
|
| PA |
D000991
|
|
| prefLabel |
Dabigatran
|
|
| RR |
SC7NUW5IIT 2E18WX195X
|
|
| TERMUI |
T783338 T643746 T000881562 T000881561 T000881563 T786560
|
|
| TH |
NLM (2016) NLM (2005) USAN (19XX) INN (19XX) FDA SRS (2015) NLM (2011)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |